Biological Testing Facility for Contraception & Reproductive Health
NICHD will soon invite applications for access to a cutting-edge facility to support research and development of new contraceptive and reproductive health products.
Funder: National Institutes of Health
Due Dates (Anticipated): January 2027 (full application deadline, projected) | January 2026 (application deadline, projected)
Funding Amounts: Not specified; award provides access to NIH Biological Testing Facility (X01 resource access mechanism).
Summary: Supports access to a state-of-the-art biological testing facility for advancing contraceptive and reproductive health product development.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.
Description
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to issue a Notice of Funding Opportunity (NOFO) for researchers seeking access to a Biological Testing Facility (BTF) dedicated to contraception and reproductive health product development. The facility will support the advancement of innovative, validated methods for fertility regulation and new therapies for reproductive health. This opportunity utilizes the X01 resource access mechanism, which provides research resources rather than direct financial support. The goal is to accelerate translational research and clinical development in the field of reproductive health.
